Target intelligence / Profile preview

Signal transducer and activator of transcription 1–Interferon regulatory factor 1–Acyl-CoA synthetase long-chain family member 4 pathway (STAT1–IRF1–ACSL4 pathway)

Target
STAT1–IRF1–ACSL4 pathway
Molecular classification
Transcription factor, Enzyme, Signaling pathway, Other
01

Overview

The STAT1–IRF1–ACSL4 pathway is a critical signaling axis that mediates the induction of ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation (Wang et al., 2019, Nature; Kong et al., 2023, Redox Biology). Activation of the pathway is typically initiated by interferon-gamma (IFNγ), which triggers the phosphorylation of Signal Transducer and Activator of Transcription 1 (STAT1). Phosphorylated STAT1 translocates to the nucleus to induce the expression of Interferon Regulatory Factor 1 (IRF1), which subsequently binds to the promoter of the Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) gene to upregulate its transcription (Kong et al., 2023, Redox Biology). ACSL4 serves as the key executioner by facilitating the esterification of polyunsaturated fatty acids (PUFAs), such as arachidonic acid, into phospholipids, thereby increasing the cell's susceptibility to oxidative damage and ferroptotic death (Jiang et al., 2021, Nat Rev Mol Cell Biol). This pathway is a major mechanism by which CD8+ T cells exert anti-tumor activity during immunotherapy, as they secrete IFNγ to promote ferroptosis in cancer cells (Wang et al., 2019, Nature). Conversely, dysregulation of this axis is implicated in pathological conditions like radiation-induced intestinal injury (RIII), where its inhibition may offer therapeutic protection (Kong et al., 2023, Redox Biology).

Other names
IFNγ–STAT1–IRF1–ACSL4 axisSTAT1/IRF1/ACSL4 signaling pathwayIFN-gamma–STAT1–IRF1–ACSL4 pathwaySTAT1-IRF1-ACSL4 axis
02

Mechanism of action

Interferon-gamma (IFNγ) activates the JAK-STAT1 signaling pathway, leading to the phosphorylation and nuclear translocation of STAT1. STAT1 induces the transcription of IRF1, which then binds to the promoter region of the ACSL4 gene to upregulate its expression. ACSL4 catalyzes the esterification of long-chain polyunsaturated fatty acids (PUFAs) into phospholipids, which are the primary substrates for lipid peroxidation, thereby sensitizing the cell to ferroptotic death (Wang et al., 2019; Kong et al., 2023).

03

Biological functions

FerroptosisLipid metabolismImmune responseSignal transductionCell death
04

Disease associations

CancerRadiation-induced intestinal injuryInflammationIschemia-reperfusion injuryAtherosclerosis
05

Safety considerations

Systemic ferroptosis-induced tissue toxicityImmunosuppression from upstream JAK/STAT inhibitionPotential for exacerbating inflammatory tissue damage in non-target organsMetabolic disturbances related to lipid remodeling
06

Interacting drugs

Interferon gamma

7 more in the full profile.

07

Biomarkers

ACSL4 protein expressionSTAT1 phosphorylation (p-STAT1)IRF1 mRNA levelsMalondialdehyde (MDA)4-Hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Signal transducer and activator of transcription 1–Interferon regulatory factor 1–Acyl-CoA synthetase long-chain family member 4 pathway (STAT1–IRF1–ACSL4 pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Signal transducer and activator of transcription 1–Interferon regulatory factor 1–Acyl-CoA synthetase long-chain family member 4 pathway (STAT1–IRF1–ACSL4 pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call